chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On Mon, Nov 22nd at approximately 10am, started having heart palpitations and heart racing that caused nausea, dizziness, light headedness and sweating.  Had pressure and discomfort on the left side of the chest, near the outside of the breast, pressure in the neck and behind the eyes.  When symptoms did not subside, primary care doctor advised to seek treatment at local emergency room.  Checked into the ER at approximately 12:20pm and after physical exam, EKG, blood tests and chest X-rays, symptoms subsided, all tests came back negative and was released to go home at approximately 3:30pm.  Followed up with primary care doctor the next day when I woke at 7am Tues, Nov 23rd with similar symptoms which subsided around 10am and they advised to seek out consultation and monitoring with a local cardiologist to check for heart damage.  Have appointment scheduled on Tues, Dec 7th.
Information has been received from a physician concerning an approximately 19 year old female who in approximately December 2002 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine as part of an immunologic work up. The physician reported that after vaccination, the pt had an anaphylactic reaction that required treatment at an ER.  The treatment details were unknown. It was noted that the pt recovered, but did not seroconvert. About three months later, in approximately March 2003, the pt was revaccinated with pneumococcal 4 6B 14 18C 19F 23F conj vaccine (CRM197) (Prevnar) and had another anaphylactic reaction with the same outcome. A product quality complaint was not involved. Additional information was received from manufacturer and was assigned manufacturer report number. The information indicated that the date of the vaccination and the adverse event was approximately two years ago. Anaphylactic reaction was considered to be immediately life threatening. Additional information has been requested.
Pt states that she got her second Pfizer COVID19 vaccine on 01/20/2021 and about 20 minutes after while driving home began to feel swelling in her throat, and trouble breathing. Pt is a NP at Medical Center and was given IM diphenhydramine at work which seemed to improve symptoms and was able to finish her shift. Pt states that later that night at about 10pm symptoms respiratory returned, with swelling of the throat, wheezing and worsening trouble breathing than earlier. Pt states she checked BP, did not have hypotension, and no rash. Pt denied any GI symptoms or abdominal pain.   Pt reports  she administered epinephrine to herself via autoinjector along with benadryl which resolved the symptoms after about an hour.  Of Note, patient reached out to us via telemedicine the next day, after this reported event occurred
Patient?s health was declining gradually . The day following second  vaccine dose she stopped eating and taking meds , went to bed and died on Monday, 2/15/2021.  I believe that the vaccine  effect on her health caused her to die  sooner than she would have from CHF  on its own path.
First 20 minutes fine. Next hour-extreme energy/adrenaline. More than ever experienced.  Next 3-4 hours- Severe brain fog, confusion, lack of concentration and mental dysfunction. Lack of clarity, rational thinking and precise understanding. Felt like  an inability to talk, make sound decisions or focus. Also feelings of eyes bulging and short temporary numb bottom lip. Feelings of brain abnormality and being drugged.  Hour to two after-Feelings of coming down from days of an extreme caffeine high with no sleep.   Worried, is mildly putting my reaction to the vaccine reaction/side effects. It was terrifying. I thought, I may not return from the negative adverse effects I was having. Something was certainly not right.   It is something, I?m not sure I can go through again. Especially, with the second shot being stronger than the first. I was incapable of doing anything!
After discharge while pt was still in the clinic she started to feel cold, and felt a burning sensation on her skin. She went to the bathroom where she noticed hives on her legs. Notified medical staff and she was brought to an exam room. I was notified and when I arrived she was sitting in a chair, alert but shivering. Erythematous urticarial rash noticed on b/l thighs and later on sides of abdomen and on arms. She started to complain of some shortness of breath and throat tightening. Paramedics were called. Lungs clear on exam and no edema of pharynx noted. O2 sat was 99%. She was administered EPIPEN 0.3mg IM to L thigh at 5:40pm and very soon after this she reported that throat tightening and shortness of breath were improving. Vitals at 5:42pm: BP 122/80, HR 92 bpm, O2 sat 99%. Paramedics arrived and pt was transported to ER. She was advised to return to sign ROI and schedule ER follow-up.
Circular rash at injection site 8 days later.  Lasted a couple of days.  Not itchy or sore just visual and a little hard
1st dose 17months ago, 2nd not yet; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (17 months ago received 1st dose).   On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 12-JAN-2023 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient forgot to get the 2nd shot. The reporter wanted to know if it was too late to get the 2nd one now and need to start over with the 1st shot. The follow-up could not be possible as no contact details were available. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.
Patient said she had a reaction to shingles vaccine - itchy rash from her neck to her head. Dermatologist treated her with shingle meds: VALTREX and Gabapentin.
undergone second COVID-19 PCR nasal swab test and tested positive; undergone second COVID-19 PCR nasal swab test and tested positive; COVID-19 virus antibody test negative; This is a spontaneous report from by a contactable consumer (patient). A 24-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8982) via an unspecified route of administration in the left arm on 16Jan2021, (age at vaccination: 24-year-old) as a single dose for COVID-19 immunisation. The patient medical history including any illness at time of vaccination was none. The concomitant medication was not reported. History of all previous immunization with the Pfizer vaccine considered as suspect was none. It was reported that the patient undergone laboratory test COVID-19 PCR nasal swab test was negative on 21Jan2021, COVID-19 virus antibody test was negative on 27Jan2021, She said she had undergone second COVID-19 PCR nasal swab test and tested positive on 29Jan2021. She said her state's health department was unsure if she would be able to get the second COVID-19 vaccine dose, and her doctor was unsure if she should get the second COVID-19 Vaccine dose. The caller asked once she was done with her quarantine period, is it ok for her to get the second COVID-19 vaccine dose. The patient received Zicam (Z101124, Expiration Date: Nov2022) as a therapeutic measure for the event undergone second COVID-19 PCR nasal swab test and tested positive. Additional vaccines administered on same date of the Pfizer suspect was none. The patient didn't receive any vaccine within 4 weeks prior vaccination. The patient didn't visit emergency room and physician office. The outcome of the events was unknown.
TC from mom 5/4/16. Received #3 HPV 5/3/16 pm. Developed a fever only 101.6->102.5. No other symptoms.
On 12/19/18, I received facial cosmetic fillers. I have had facial cosmetic fillers in the past with no adverse effects. I had no side effects after receiving the fillers. The specific brand of filler was in my nasolabial area and in my cheeks. On 1/5/19, I received my second dose of the SHINGRIX vaccine, 18 days after having received the facial fillers. The initial side effect from the injection was soreness in my left arm which I had with the first dose. On 1/7/19, I woke up and my lips, nasolabial area and cheeks were swollen and hard. I took 2 Benadryl tablets over the course of the day without any change in symptoms. By the end of the day, the swelling had gone and the cosmetic fillers were gone. My immune system had attacked the fillers and eliminated them.
Diarrhea the day of vaccination and the day after, 10 episodes.  Fever, 102 degrees,started the day after vaccination and lasted for 3 days.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients. On an unknown date, the unspecified number of patients were vaccinated with RECOMBIVAX HB (lot #, dose, route not reported), which were improperly stored. No adverse effects reported. This is one of several reports received from the same source. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. Additional information has been requested.
shingles on both sides of his face within days of receiving the first dose of Shingrix; This case was reported by a nurse via sales rep and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The patient developed shingles on both sides of his face within days of receiving vaccine. The patient reported adverse event to pharmacy as well. The reporter consented to follow up.
Arm pain at injection site; Arm weakness; Immobility through shoulder continuous; This is a spontaneous report form a contactable consumer (patient). A 43-year-old non-pregnant female patient (patient was not pregnant at the time of vaccination) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8727), via an unspecified route of administration in left arm on 22May2021 (at the age of 43-years-old) as a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received unspecified birth control pills only medications received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine in four weeks of COVID vaccination. On 26May2021, the patient experienced arm pain at injection site 6 weeks after injection and arm weakness and immobility through shoulder continuous. The reporter reported seriousness criteria is Disabling/Incapacitating. As a corrective measure, the patient attended physician therapy. The adverse event was resulted in a visit to doctor or other healthcare professional office/clinic visit. The outcome of the events was resolving.  Amendment: This follow-up report is being submitted to amend previously reported information: this case upgrade to serious since reported seriousness criteria is Disabling/Incapacitating for all events.
Patient had decreased limp mobility at injection arm and had a fever. Advised to take 1 200 mg ibuprofen tablet before Dr. appt.
This is a spontaneous report from a contactable consumer, who is also the patient. This male patient of an unspecified age received TRUMENBA via an unspecified route of administration on 11Jul2018 at single dose for immunisation. Relevant medical history and concomitant medications were not reported. The patient reported that he received meningococcal group b rlp2086 1 day prior to this report and experienced joint pain, chills, headache, general body soreness, fatigue and redness at the injection site in Jul2018. The outcome of the events was unknown.
Fever; Muscle aches; Extreme fatigue; Became ill after the first dose; This case was reported by a other health professional via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In December 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced fever, muscle pain, fatigue and feeling unwell. On an unknown date, the outcome of the fever, muscle pain, fatigue and feeling unwell were recovered/resolved.   It was unknown if the reporter considered the fever, muscle pain, fatigue and feeling unwell to be related to Shingrix.   Additional details were provided as follows: The age at vaccination was not reported. The age group was selected as adult as per product indication. After the 1st dose of Shingrix the patient became ill, fever, muscle ache, extreme fatigue for 48 hour. For tolerance in 2nd dose refer case US2020AMR208102.
Itching all over arms and torso after immunization.  He took Benadryl and issue resolved
Received vaccines on Saturday 1130 AM. That evening arm felt hot & pt got chills & fever. Pt treated w/ APAP & cold pack. Took shower & noticed redness. Red spots went down midway on the arm. Pt developed cough on Sunday, fever & chills.
Rash, general weakness, tachycardia, severe abdominal pain and upset and back pain.
This spontaneous report as received on 19-AUG-2014 from Registered Nurse refers to a numerous children (unspecified), exact age and gender not reported. On an unknown date, the patients were vaccinated with GARDASIL (dose, route, lot number reported). Secondary suspect therapy included other unspecified vaccines (dose, route, date of administration, lot number not reported). Registered nurse stated that recently (in an approximately 2014), they have numerous children (unspecified) who have had fainting episodes after receiving GARDASIL and other unspecified vaccines. The outcome of fainting episodes was not reported. The relatedness between GARDASIL, other unspecified vaccines and fainting episodes was unknown. This is one of several reports received from the same reporter. Additional information is not expected, questionnaires previously sent to reporter were returned.
This case was reported by a consumer, the subject's significant other and described the occurrence of central nervous system effects in a 43-year-old male subject who was vaccinated with FLULAVAL (GlaxoSmithKline). A physician or other health care professional has not verified this report. On 15 October 2011 the subject received unspecified dose of FLULAVAL (unknown). Expiration date was reported as 26 July 2011, GSK lot number records for AFLLA694AA had an expiration of 30 June 2012. In November 2011, 1 month after vaccination with FLULAVAL, the subject experienced central nervous system effects, body twitch, feeling hot, cold feeling, twinge, tingling, ill defined disorder and sensory disturbances. The subject has had several central nervous system side effects to FLULAVAL starting about a month after his vaccination on 15 October 2011 he began experiencing hot and cold sensations, twitching and tingling. These sensations started in his head and moved to his extremities. They appear in different parts of his body, jumping around. The reporter described "his energy flow as being off. Parts of his body can feel either hot or cold. For example he could wake up and his head would feel very cold and he would have to wear a hat. Limbs can twitch randomly". The reporter declined to be contacted for follow-up. At the time of reporting the events were worse.
This spontaneous report was received from a back office lead and refers to a 39 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 25-MAR-2016, the patient was vaccinated with the improperly stored dose of RECOMBIVAX HB (1 ml, intramuscularly in left deltoid, lot # reported as 042846 (verified to be non-valid), expiration date 15-SEP-2017). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information is not expected as all the correspondence was returned by the post office.
redness, swelling and pain started 7 days after with a rash that is now covering half the circumference of arm.
Red, hot, swelling and itching below injection site.  Area involved lower deltoid to elbow and around parts of upper arm.  Accompanied by low  fever and feeling aches all over. Began to feel better 3-4 days later and arm took about 5-6 days to fully resolve swelling, itching, heat
15 minutes after patient left the clinic and was driving home, he developed a metallic taste in his mouth. He called his wife who told him he might pass out and should pull over. He stopped and put on his hazard lights. His vision started to tunnel and he did pass out for about 5 minutes. After coming to, he continued the drive home, about 2 more miles. He did feel shaky for several more hours but no further symptoms. He did not contact his provider.
4/6 - slight headache at night took Tylenol (1000mg) 4/7 - low grade fever, headache, nauseous,  and extreme fatigue took Tylenol (1000 mg) twice(afternoon and night) At night started to feel tingling and numbness in feet.  4/8- headache mid afternoon took Tylenol (1000mg), numbness and tingling started in feet, lower legs, arms and hands. Started menstrual spotting. 4/9 - Numbness and tingling in feet, lower legs, arms and hands all day and nauseous mid afternoon through the night. Took Tylenol at night (1000mg). 4/10 -  Numbness and tingling in feet, lower legs, arms and hands all day. 4/11 - Woke up with a bad headache took Tylenol (1000mg), headache continued took more Tylenol mid afternoon.
Immediately after receiving the 2 vaccines patients eyes rolled back, fell over on exam table hands drew up and was shaking like in a seizure. We laid him down and placed cold packs on head and he regained consciousness and observed 20 min. and felt better.
13NOV94 according to mom pt w/t103-104 gave feverall supp 120mg, shortly p/ pt stiffened up, eyes rolled back & jerked, lasted seconds; called CMT's, who arrived 15 mins later, no further episodes witnessed; seen in ER- inc WBC;
After receiving my second injection I began having dizziness, ear pressure,  pulsatile tinnitus and migraine headaches with a visual aura about 4-5 times per week. I followed up with my rheumatologist in April who referred me to ENT. ENT ordered a functional audiogram which was normal. They also ordered a brain MRI which was unremarkable aside from an incidental finding of a Rathke Cyst. I was then referred to a neuratologist who diagnosed me with inner ear and ocular migraines likely secondary to an autoimmune dysfunction.  Prior to the vaccine I was seeing a rheumatologist for autoimmune symptoms, however, the abovementioned symptoms were new onset following the vaccine.
Severe fatigue began that night as well as muscle fatigue. I experienced night sweats for 2 nights as well as chills. The 2nd day after vaccine I was also heavily fatigued, hardly left cough, light headache, some nausea.
pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 18-Sep-2020 and the estimated date of delivery was 27-Jun-2021. On 19-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-sixth week of the pregnancy.  On 19-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.  No treatment medications reported.
On 6/17/2004 about 6:00 pm he complained of itching and mom noticed his right arm felt hot to the touch and was swollen. Mom is here today 6/18/04 at 11:30am.
Extreme swelling of her arm from shoulder to elbow.  Red, hard and very hot entire upper arm. Shot given Friday afternoon December 2.  Swelling started Saturday morning (Dec 3).  Patient seen back at the clinic Sunday evening (Dec 4) due to severe pain.  Patient started on antibotics and topical cream.  Patient seen again Monday evening Dec 5.  Swelling had become worse. Patient has continued treament and swelling has gone down.  Area is still hard, but temperature has returned to normal (Dec 8).
Red patchy face, felt like a sunburn later severe headache, chills, fever, rapid heartbeat, stopped14 hours later, slight headache 72 hours later left eye pain, 84 hours later left eye swelling, went to PCP.  Put on antibiotics and eye drops returned to PCP no improvement. The swelling got worse on Thursday, April 15 was admitted to hospital for orbital cellulitis. Lab tests, CT scan and recieved iv antibiotics and steroids. Discharged diagnosed as periorbital cellulitis on Saturday April 17 was put on oral antibiotics and eyedrops.